The Hyderabad-based pharmaceutical firm Suven Life Sciences announced on May 13 that the firm has been granted patents in Europe and Hong Kong for a drug used in the treatment of neurodegenerative diseases like Alzheimer's, Schizophrenia and Parkinson's.
The firm said during the trading hours at the Bombay Stock Exchange, "One product patent from Europe and one product patent from Hong Kong corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases".
Three New Product Patents for Suven Life Sciences
Suven Life Sciences haas secured three product patents which are useful for treating neurodegenerative disorders.
Advertisement
Suven has a total of 16 granted patents from Europe and 17 from Hong Kong, including these two patents.
Venkat Jasti, CEO of Suven Life Sciences, said, "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS (central nervous system) arena that are being developed for cognitive disorders with high unmet medial need with huge market potential globally."
The granted patents are exclusive intellectual property of Suven and the products out of these inventions may be out-licensed at various phases of clinical development.
Source: Medindia
The granted patents are exclusive intellectual property of Suven and the products out of these inventions may be out-licensed at various phases of clinical development.
Source: Medindia
Suven Life Sciences Starts Phase I Trial for Alzheimer’s Drug
Hyderabad-based Suven Life Sciences announced that it has started Phase I clinical trial of its experimental drug.
Advertisement
 Supreme Court to Deliver Key Drug Patent RulingOn a patent challenge by Swiss drug giant Novartis that activists say threatens access to cheap generic versions of life-saving drugs in developing nations, India's Supreme Court is set to rule. | Advertisement
|
Roche’s Cancer Drug Patent Partly Revoked in India
Roche confirmed that the Indian government has partly revoked the patents granted for its breast cancer drug Herceptin.
Advertisement
Recommended Reading
Latest Drug News
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial